Show simple item record

dc.contributor.authorJmii, H
dc.contributor.authorHalouani, A
dc.contributor.authorElmastour, F
dc.contributor.authorIfie, E
dc.contributor.authorRichardson, SJ
dc.contributor.authorSane, F
dc.contributor.authorMokni, M
dc.contributor.authorAouni, M
dc.contributor.authorHober, D
dc.contributor.authorJaïdane, H
dc.date.accessioned2016-09-28T15:57:21Z
dc.date.issued2016-09-20
dc.description.abstractCoxsackie B viruses (CV-B) are important pathogens associated with several central nervous system (CNS) disorders. CV-B are mainly transmitted by the faecal-oral route, but there is also evidence for vertical transmission. The outcome of in utero CV-B infections on offspring's CNS is poorly explored. The aim of this study was to investigate vertical transmission of CV-B to the CNS. For this purpose, pregnant Swiss albino mice were intraperitoneally inoculated with CV-B4 E2 at gestational days 10G or 17G. Different CNS compartments were collected and analyzed for virus infection and histopathological changes. Using plaque assays, we demonstrated CV-B4 E2 vertical transmission to offspring's CNS. Viral RNA persisted in the CNS up to 60 days after birth, as evidenced by a sensitive semi-nested(sn) reverse transcripton(RT)-PCR method. This was despite infectious particles becoming undetectable at later time points. Persistence was associated with inflammatory lesions, lymphocyte infiltration and viral dsRNA detected by immunohistochemistry. Offspring born to dams mock- or virus-infected at day 17G were challenged by the same virus at day 21 after birth (-+ and ++ groups, respectively). Sn-RT-PCR and histology results compared between both ++ and -+ groups, show that in utero infection did not enhance CNS infection during challenge of the offspring with the same virus.en_GB
dc.description.sponsorshipThis work was supported by Ministère de l’Enseignement Supérieur et de la Recherche Scientifique, (LR99ES27), Tunisia, and Ministère de l’Education Nationale de la Recherche et de la Technologie, Université Lille 2 CHRU Lille (UPRES EA3610), France. Financial support for S.J.R has come from the European Commission 7th Framework Programme PEVNET [FP7/2007-2013] under grant agreement number 261441 and a Juvenile Diabetes Research Foundation (JDRF) Career Development Award (5-CDA-2014-221-A-N). Habib JMII was supported by grants from Ministère de l’Enseignement Supérieur et de la Recherche Scientifique.en_GB
dc.identifier.citationDOI: http://dx.doi.org/10.1093/femspd/ftw096en_GB
dc.identifier.doi10.1093/femspd/ftw096
dc.identifier.otherftw096
dc.identifier.urihttp://hdl.handle.net/10871/23676
dc.language.isoenen_GB
dc.publisherOxford University Press (OUP)en_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/27655912en_GB
dc.rights.embargoreasonPublisher policyen_GB
dc.subjectCentral nervous system (CNS)en_GB
dc.subjectPersistenceen_GB
dc.subjectType B Coxsackieviruses (CV-B)en_GB
dc.subjectVertical transmissionen_GB
dc.titleCentral nervous system infection following vertical transmission of Coxsackievirus B4 in miceen_GB
dc.typeArticleen_GB
dc.descriptionThis is the author accepted manuscript. The final version is available from the publisher via the DOI in this record.en_GB
dc.identifier.journalPathogens and Diseaseen_GB
dc.identifier.pmcid27655912


Files in this item

This item appears in the following Collection(s)

Show simple item record